Delivery Order SPE2DB20D3103-SPE2DB24FN8L9
- Not listed
- This federal contract award, valued at $27,992.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565405069 ADACEL TDAP SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of August 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type and has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,575.00 Firm Fixed Price contract is for the delivery of ADACEL TDAP SYRINGE 0.5ML medical supplies. The contract has an ultimate completion date of December 3, 2024 and was awarded on December 2, 2024. This award is a delivery order against Amerisourcebergen's larger $999,999,999...
- This is a $1,742.00 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADACEL TDAP SYRINGE 5S, a medical supply item, with a completion date of July 3, 2025. The award is under a Firm Fixed Price contract type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,526.88, is a Firm Fixed Price Delivery Order for the supply of ADACEL TDAP SYRINGE 5S, a medical product. The award has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,831.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,388,085 units of the ADACEL TDAP VIAL 0.5ML pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This federal contract award, valued at $1,272.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563935683 ADACEL TDAP SYRINGE 0.5ML, with a completion date of March 13, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $71,498.26, is for the delivery of ADACEL TDAP SYRINGE 0.5ML medical supplies. The contract is a firm fixed-price delivery order with a period of performance through May 17, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,577.00 firm fixed-price delivery order is for the supply of ADACEL TDAP syringes (0.5 mL). The award, which has a completion date of June 29, 2023, is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,257.02 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of ADACEL TDAP VIAL 0.5ML pharmaceutical products. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ADACEL TDAP SYRINGE 0.5ML. The firm-fixed-price contract, valued at $1,340.00, has a completion date of June 13, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN8L9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 4564618676 ADACEL TDAP SYRINGE 0.5ML. The contract is a Delivery Order with a Firm Fixed Price of $60,253.60 and an ultimate completion date of May 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This particular award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.3k | 5/15/24 |